SEC Form D private-offering filing

NexEos Diagnostics, Inc.

Name: NexEos Diagnostics, Inc. - new SEC Form D private-offering filing, Chester Springs, PA
Published: 2026-02-17

A new SEC Form D private-offering notice from Chester Springs, PA, a $3,000,000 filer-stated offering target in Biotech. The source filing is one click away.

NexEos Diagnostics, Inc. site↗ Verified via SEC Form D

Develops diagnostics and therapies for eosinophil mediated inflammatory diseases such as eosinophilic esophagitis, under the brand NexEos Bio

Filed 2026-02-17Filed to raise $3,000,000First money in 2026-02-02Raised so far $3,000,000HQ (as filed) Chester Springs, PASector Biotech ✓Stage (inferred) SeedCall status Call-ready

Source linked the Form D on EDGAR↗Website verified nexeosbio.com↗Named in the filing 7 executives & directors

Open this row on the live feed →More new filings in Pennsylvania →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.